Christine A. Poon, a director at Regeneron Pharmaceuticals ($REGN), sold shares on the open market six times in the last year, totaling about $4.25 million. Her most recent sale occurred on October 29, 2025. These sales rank her 2,166th among 11,678 individual insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2025 Restricted Stock Units | 26 | $92.34 | 1,765.0000 | 351,800,000 | 1.50% | 0.00% |
| March 12, 2026 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 201 | $92.34 | 13,501.0000 | 351,800,000 | 1.51% | 0.00% |
| March 12, 2026 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 61 | $92.34 | 4,144.0000 | 351,800,000 | 1.49% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | A | Common Stock | 155 | $0.00 | 5,219.0000 | 137,600,000 | 3.06% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | A | Non-Qualified Stock Option (right to buy) | 1962 | $0.00 | 1,962.0000 | 137,600,000 | 9999.99% | 0.00% |
| Dec. 11, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 151 | $117.05 | 13,299.0000 | 352,800,000 | 1.15% | 0.00% |
| Dec. 11, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2025 Restricted Stock Units | 19 | $117.05 | 1,738.0000 | 352,800,000 | 1.11% | 0.00% |
| Dec. 11, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 46 | $117.05 | 4,082.0000 | 352,800,000 | 1.14% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 100 | $655.10 | 3,452.0000 | 136,200,000 | 2.82% | 0.00% |
| Oct. 30, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | M | Non-Qualified Stock Option (right to buy) | 2712 | $0.00 | 0.0000 | 136,200,000 | 100.00% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | M | Non-Qualified Stock Option (right to buy) | 6500 | $0.00 | 2,712.0000 | 136,200,000 | 70.56% | 0.00% |
| Oct. 30, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | M | Common Stock | 2712 | $520.01 | 5,064.0000 | 136,200,000 | 115.31% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 388 | $657.29 | 2,352.0000 | 136,200,000 | 14.16% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 712 | $656.50 | 2,740.0000 | 136,200,000 | 20.63% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | M | Common Stock | 6500 | $520.01 | 8,852.0000 | 136,200,000 | 276.36% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 650 | $652.68 | 8,202.0000 | 136,200,000 | 7.34% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 2735 | $653.50 | 5,467.0000 | 136,200,000 | 33.35% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 1915 | $654.42 | 3,552.0000 | 136,200,000 | 35.03% | 0.00% |
| Sept. 11, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2025 Restricted Stock Units | 21 | $106.99 | 1,718.0000 | 357,500,000 | 1.24% | 0.00% |
| Sept. 11, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 50 | $106.99 | 4,035.0000 | 357,500,000 | 1.25% | 0.00% |
| Sept. 11, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 163 | $106.99 | 13,148.0000 | 357,500,000 | 1.26% | 0.00% |
| June 12, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2025 Restricted Stock Units | 21 | $104.90 | 1,697.0000 | 357,500,000 | 1.25% | 0.00% |
| June 12, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 50 | $104.90 | 3,985.0000 | 357,500,000 | 1.27% | 0.00% |
| June 12, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 164 | $104.90 | 12,984.0000 | 357,500,000 | 1.28% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | POON CHRISTINE A | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | POON CHRISTINE A | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | POON CHRISTINE A | Director | M | Common Stock | 1435 | $0.00 | 1,435.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 13, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2025 Restricted Stock Units | 1675 | $0.00 | 1,675.0000 | 357,500,000 | 9999.99% | 0.00% |
| May 13, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | M | 2024 Restricted Stock Units | 1321 | $0.00 | 0.0000 | 357,500,000 | 100.00% | 0.00% |
| May 13, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | D | Common Stock | 1321 | $107.40 | 11,583.0000 | 357,500,000 | 10.24% | 0.00% |
| May 13, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | M | Common Stock | 1321 | $0.00 | 12,904.0000 | 357,500,000 | 11.40% | 0.00% |
| April 4, 2025 | SHERWIN WILLIAMS CO | $SHW | POON CHRISTINE A | Director | A | Common Stock | 4 | $338.25 | 14,959.3800 | 254,100,000 | 0.03% | 0.00% |
| March 13, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 162 | $105.04 | 12,819.0000 | 357,500,000 | 1.28% | 0.00% |
| March 13, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 49 | $105.04 | 3,934.0000 | 357,500,000 | 1.26% | 0.00% |
| March 13, 2025 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2024 Restricted Stock Units | 16 | $105.04 | 1,321.0000 | 357,500,000 | 1.23% | 0.00% |
| Feb. 18, 2025 | SHERWIN WILLIAMS CO | $SHW | POON CHRISTINE A | Director | A | Common Stock | 517 | $0.00 | 14,949.3500 | 254,100,000 | 3.58% | 0.00% |
| Jan. 3, 2025 | SHERWIN WILLIAMS CO | $SHW | POON CHRISTINE A | Director | A | Common Stock | 25 | $335.00 | 14,432.3500 | 254,100,000 | 0.17% | 0.00% |
| Dec. 20, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | W | Common Stock | 14 | $0.00 | 2,186.0000 | 135,300,000 | 0.64% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | A | Non-Qualified Stock Option (right to buy) | 1958 | $0.00 | 1,958.0000 | 136,000,000 | 9999.99% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | A | Common Stock | 166 | $0.00 | 2,352.0000 | 136,000,000 | 7.59% | 0.00% |
| Dec. 12, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 41 | $120.61 | 3,884.0000 | 358,300,000 | 1.07% | 0.00% |
| Dec. 12, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 134 | $120.61 | 12,656.0000 | 358,300,000 | 1.07% | 0.00% |
| Dec. 12, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2024 Restricted Stock Units | 13 | $120.61 | 1,304.0000 | 358,300,000 | 1.01% | 0.00% |
| Oct. 4, 2024 | SHERWIN WILLIAMS CO | $SHW | POON CHRISTINE A | Director | A | Common Stock | 23 | $372.47 | 14,402.5000 | 254,600,000 | 0.16% | 0.00% |
| Sept. 12, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 42 | $115.84 | 3,843.0000 | 363,500,000 | 1.10% | 0.00% |
| Sept. 12, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 138 | $115.84 | 12,521.0000 | 363,500,000 | 1.11% | 0.00% |
| Sept. 12, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2024 Restricted Stock Units | 14 | $115.84 | 1,290.0000 | 363,500,000 | 1.10% | 0.00% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | M | Common Stock | 10838 | $413.33 | 13,010.0000 | 134,800,000 | 498.99% | 0.01% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | M | Non-Qualified Stock Option (right to buy) | 10838 | $0.00 | 0.0000 | 134,800,000 | 100.00% | 0.01% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 212 | $1158.02 | 7,858.0000 | 134,800,000 | 2.63% | 0.00% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 234 | $1160.45 | 2,272.0000 | 134,800,000 | 9.34% | 0.00% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 5352 | $1159.56 | 2,506.0000 | 134,800,000 | 68.11% | 0.00% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 100 | $1161.32 | 2,172.0000 | 134,800,000 | 4.40% | 0.00% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 1560 | $1157.33 | 8,070.0000 | 134,800,000 | 16.20% | 0.00% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 2368 | $1156.30 | 9,630.0000 | 134,800,000 | 19.74% | 0.00% |
| Aug. 15, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 1012 | $1155.72 | 11,998.0000 | 134,800,000 | 7.78% | 0.00% |
| July 5, 2024 | SHERWIN WILLIAMS CO | $SHW | POON CHRISTINE A | Director | A | Common Stock | 29 | $295.50 | 14,374.9000 | 258,300,000 | 0.20% | 0.00% |
| June 13, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2024 Restricted Stock Units | 14 | $113.97 | 1,276.0000 | 363,500,000 | 1.11% | 0.00% |
| June 13, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 139 | $113.97 | 12,382.0000 | 363,500,000 | 1.14% | 0.00% |
| June 13, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 42 | $113.97 | 3,800.0000 | 363,500,000 | 1.12% | 0.00% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POON CHRISTINE A | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POON CHRISTINE A | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 14, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2024 Restricted Stock Units | 1261 | $0.00 | 1,261.0000 | 363,500,000 | 9999.99% | 0.00% |
| May 9, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | D | Common Stock | 1935 | $117.95 | 11,583.0000 | 363,500,000 | 14.31% | 0.00% |
| May 9, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | M | Common Stock | 1935 | $0.00 | 13,518.0000 | 363,500,000 | 16.71% | 0.00% |
| May 9, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | M | 2023 Restricted Stock Units | 1935 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| April 5, 2024 | SHERWIN WILLIAMS CO | $SHW | POON CHRISTINE A | Director | A | Common Stock | 25 | $331.56 | 14,340.3400 | 258,300,000 | 0.18% | 0.00% |
| March 14, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | 2023 Restricted Stock Units | 22 | $111.74 | 1,935.0000 | 363,500,000 | 1.15% | 0.00% |
| March 14, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Optional | 43 | $111.74 | 3,757.0000 | 363,500,000 | 1.16% | 0.00% |
| March 14, 2024 | PRUDENTIAL FINANCIAL INC | $PFH | POON CHRISTINE A | Director | A | Notional Shares - Mandatory | 140 | $111.74 | 12,243.0000 | 363,500,000 | 1.16% | 0.00% |
| Feb. 13, 2024 | SHERWIN WILLIAMS CO | $SHW | POON CHRISTINE A | Director | A | Common Stock | 594 | $0.00 | 14,309.8300 | 258,300,000 | 4.33% | 0.00% |
| Jan. 5, 2024 | SHERWIN WILLIAMS CO | $SHW | POON CHRISTINE A | Director | A | Common Stock | 28 | $296.96 | 13,715.8300 | 258,300,000 | 0.21% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | A | Non-Qualified Stock Option (right to buy) | 1607 | $0.00 | 1,607.0000 | 133,100,000 | 9999.99% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | A | Common Stock | 135 | $0.00 | 2,172.0000 | 133,100,000 | 6.63% | 0.00% |
| Aug. 23, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 3032 | $839.45 | 8,987.0000 | 130,400,000 | 25.23% | 0.00% |
| Aug. 23, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 6450 | $840.65 | 2,537.0000 | 130,400,000 | 71.77% | 0.00% |
| Aug. 23, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 500 | $841.05 | 2,037.0000 | 130,400,000 | 19.71% | 0.00% |
| Aug. 23, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | M | Non-Qualified Stock Option (right to buy) | 12280 | $0.00 | 0.0000 | 130,400,000 | 100.00% | 0.01% |
| Aug. 23, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 300 | $837.92 | 14,017.0000 | 130,400,000 | 2.10% | 0.00% |
| Aug. 23, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | S | Common Stock | 1998 | $838.60 | 12,019.0000 | 130,400,000 | 14.25% | 0.00% |
| Aug. 23, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | M | Common Stock | 12280 | $273.67 | 14,317.0000 | 130,400,000 | 602.85% | 0.01% |
| July 11, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | POON CHRISTINE A | Director | A | Non-Qualified Stock Option | 16375 | $0.00 | 16,375.0000 | 98,900,000 | 9999.99% | 0.02% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | A | Common Stock | 165 | $0.00 | 2,037.0000 | 130,400,000 | 8.81% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | POON CHRISTINE A | Director | A | Non-Qualified Stock Option (right to buy) | 1929 | $0.00 | 1,929.0000 | 130,400,000 | 9999.99% | 0.00% |